Century Pharmaceuticals Overview

  • Founded
  • 1982
Founded
  • Status
  • Private
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $483K
Latest Deal Amount
  • Investors
  • 2

Century Pharmaceuticals General Information

Description

Developer of novel recombinant protein designed to offer treatment for asthma and allergies. The company's protein is used for the treatment and cure of asthma and mastocytosis, enabling doctors to upgrade effectiveness of drugs, improve lifestyle quality and work on unmet needs of the healthcare industry.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 406, World Trade Centre
  • Sayajigunj
  • Vadodara, Gujarat 390005
  • India
+91 0265 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Century Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 28-Jan-2012 $483K 00000 Completed Startup
1. Grant Completed Startup
To view Century Pharmaceuticals’s complete valuation and funding history, request access »

Century Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Janak Sheth Owner & Managing Director
To view Century Pharmaceuticals’s complete executive team members history, request access »

Century Pharmaceuticals Board Members (1)

Name Representing Role Since
Rishabh Sheth Century Pharmaceuticals Board Member 000 0000
To view Century Pharmaceuticals’s complete board members history, request access »

Century Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
GVFL Venture Capital Minority 000 0000 000000 0
Small Business Innovation Research and Small Business Technology Transfer Programs Government 000 0000 000000 0
To view Century Pharmaceuticals’s complete investors history, request access »